The VP and Gen’l Mgr. of ICU Medical is Exercising Options


Today it was reported that the VP and Gen’l Mgr. of ICU Medical (NASDAQ: ICUI), Thomas Mccall, exercised options to sell 11,133 ICUI shares at $78.86 a share, for a total transaction value of $3.37M.

Following Thomas Mccall’s last ICUI Sell transaction on August 12, 2016, the stock climbed by 179.4%. In addition to Thomas Mccall, one other ICUI executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on ICU Medical’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $360 million and quarterly net profit of $31.05 million. In comparison, last year the company earned revenue of $332 million and had a GAAP net loss of $37.06 million. ICUI’s market cap is $6.22B and the company has a P/E ratio of 75.81. Currently, ICU Medical has an average volume of 114.5K.

The insider sentiment on ICU Medical has been negative according to 59 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Thomas Mccall’s trades have generated a -32.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ICU Medical, Inc. is an infusion therapy company, which engages in the development, manufacturing and sale of innovative medical devices used in vascular therapy and critical care applications. The company’s product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors designed to help meet clinical, safety and workflow goals. Its customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts